Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut)     Collection: Yearbook_2015     Display Documents



ID: 711843.0, MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut) / Yearbook_2015
Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia
Authors:Witsch, T. J.; Turowski, P.; Sakkas, E.; Niess, G.; Becker, S.; Herold, S.; Mayer, K.; Vadasz, I.; Roberts, J. D.; Seeger, W.; Morty, R. E.
Date of Publication (YYYY-MM-DD):2014-02
Title of Journal:Am J Physiol Lung Cell Mol Physiol
Volume:306
Issue / Number:3
Start Page:L246
End Page:59
Audience:Not Specified
Abstract / Description:Bronchopulmonary dysplasia (BPD) is a common and serious complication of premature birth, characterized by a pronounced arrest of alveolar development. The underlying pathophysiological mechanisms are poorly understood although perturbations to the maturation and remodeling of the extracellular matrix (ECM) are emerging as candidate disease pathomechanisms. In this study, the expression and regulation of three members of the lysyl hydroxylase family of ECM remodeling enzymes (Plod1, Plod2, and Plod3) in clinical BPD, as well as in an experimental animal model of BPD, were addressed. All three enzymes were localized to the septal walls in developing mouse lungs, with Plod1 also expressed in the vessel walls of the developing lung and Plod3 expressed uniquely at the base of developing septa. The expression of plod1, plod2, and plod3 was upregulated in the lungs of mouse pups exposed to 85% O2, an experimental animal model of BPD. Transforming growth factor (TGF)-beta increased plod2 mRNA levels and activated the plod2 promoter in vitro in lung epithelial cells and in lung fibroblasts. Using in vivo neutralization of TGF-beta signaling in the experimental animal model of BPD, TGF-beta was identified as the regulator of aberrant plod2 expression. PLOD2 mRNA expression was also elevated in human neonates who died with BPD or at risk for BPD, compared with neonates matched for gestational age at birth or chronological age at death. These data point to potential roles for lysyl hydroxylases in normal lung development, as well as in perturbed late lung development associated with BPD.
Free Keywords:Animals; Animals, Newborn; Bronchopulmonary Dysplasia/enzymology/genetics/pathology/*physiopathology; Cell Line; Epithelial Cells/metabolism; Female; Humans; Hyperoxia/physiopathology; Infant, Newborn; Lung/*embryology; Male; Mice; Mice, Inbred C57BL; Pregnancy; Procollagen-Lysine, 2-Oxoglutarate; 5-Dioxygenase/biosynthesis/genetics/*metabolism; Transforming Growth Factor beta/pharmacology; Up-Regulation; bronchopulmonary dysplasia; extracellular matrix; lung development; lysyl hydroxylase
External Publication Status:published
Document Type:Article
Communicated by:MPI für Herz- und Lungenforschung
Affiliations:MPI für physiologische und klinische Forschung
External Affiliations:%^ 1435822045
Identifiers:ISSN:1522-1504 (Electronic) 1040-0605 (Linking) %R 10.1152/ajplung.00109.2013
URL:http://www.ncbi.nlm.nih.gov/pubmed/24285264
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.